Certificate number:RU.77.99.11.003.Е.001901.04.17 Date of registration and renewal:19.04.2017 Dosage form: & nbspTablets weighing 1593 mg. Classification "Composition" & nbsp BAD - vitamin and mineral complexes Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes Supplements containing zinc, copper, manganese Supplements containing calcium and phosphorus Supplements containing potassium and magnesium Supplements antioxidants Supplements that affect the functions of the cardiovascular system Supplements supporting the functions of the musculoskeletal system BAA, reducing the risk of violations of carbohydrate metabolism Supplements that affect the process of detoxification and promote the elimination of foreign and toxic substances from the body Composition: & nbspCalcium carbonate, magnesium oxide, vitamin D3, manganese sulfate II, copper sulfate II, hydroxyl-propylmethylcellulose, modified starch, stearic acid, beet powder, carboxyl methyl cellulose, magnesium stearate, MCC, iron oxide, silicon dioxide . Sheath composition: talc, hydroxyl-propyl-methyl cellulose, modified starch, hydroxyl-propyl-cellulose, olive oil. Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, the sales network departments as a biologically active food additive - an additional source of magnesium, calcium, copper, manganese, vitamin D3. Suggested Usage: & nbspAdults take 1 tablet 1 time per day with meals.Duration of admission is 2 months. After a break of 1 month, a second appointment is possible. Contraindications:Individual intolerance to components, pregnant and lactating women. Special instructions:Before use, consult a physician. Shelf life:3 years. Storage conditions:Store in a dry, protected from light place at a temperature of no higher than + 25 ° C. Research protocols:ATreplacing the certificate of state registration No. RU.77.99.11.003.Е.006447.08.14 of 06.08.2014, the expert opinion of the Federal State Unitary Enterprise ФЦГ ФЦГ and Э Роспотребнадзора № 10-2 ФЦ / 2627 from 06.06.2008, the protocol of laboratory researches ФБУЗ " ФЦГиЭ "of Rospotrebnadzor № 224 of 11.03.2014. ManufacturersKvasser Pharma GmbH & Co. KG. KG GermanyKvasser Pharma GmbH & Co. KG. KG / Queisser Pharma GmbH & Co.KG, Schleswiger Strasse 74 24941 Flensburg (Germany). Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation Information update date: & nbsp24.06.2017 Instructions